- •Preface
- •Contents
- •Contributors
- •2 Laser Subepithelial Keratomileusis (LASEK): Theoretical Advantages Over LASIK
- •4 LASEK Preoperative Considerations
- •5 LASEK Preoperative Evaluation
- •6 LASEK Techniques
- •7 Camellin LASEK Technique
- •8 Butterfly LASEK
- •9 Epithelial Flap Hydrodissection and Viscodissection in Advanced Laser Surface Ablation (ALSA)
- •12 Postoperative Management of LASEK
- •13 LASEK Enhancements
- •14 LASEK in High and Low Myopia
- •15 LASEK vs. PRK: Comparison of Visual Outcomes
- •16 LASEK vs. LASIK: Comparison of Visual Outcomes
- •18 LASEK Complications
- •19 Management of LASEK Complications
- •21 Customized Ablation and LASEK
- •22 Comparison of Wavefront-Guided Photorefractive Keratectomy and LASEK Treatments for Myopia and Myopic Astigmatism
- •24 Biochemical Basis of Epithelial Dehiscence and Reattachment After LASEK
- •25 Refractive Surgical Wound Healing Mechanisms Revisited: A Glimpse at the Future of LASEK
- •27 Mitomycin C and Surface Ablation
- •28 Use of Autologous Serum to Reduce Haze After LASEK
- •30 LASEK After Penetrating Keratoplasty
- •Index
LASEK, PRK, AND EXCIMER LASER STROMAL SURFACE ABLATION
REFRACTIVE SURGERY
Series Editors
Dimitri T.Azar, M.D.
Massachusetts Eye and Ear Infirmary
Schepens Eye Research Institute
and Harvard Medical School
Boston, Massachusetts
Douglas D.Koch, M.D.
Cullen Eye Institute
Baylor College of Medicine
Houston, Texas
1.LASIK: Fundamentals, Surgical Techniques, and Complications, edited by Dimitri T.Azar and Douglas D.Koch
2.Hyperopia and Presbyopia, edited by Kazuo Tsubota, Brian S.Boxer Wachler, Dimitri T.Azar, and Douglas D.Koch
3.LASEK, PRK, and Excimer Laser Stromal Surface Ablation, edited by Dimitri T.Azar, Massimo Camellin, Richard W.Yee
ADDITIONAL VOLUMES IN PREPARATION
Phakic and Accomodating IOLs, edited by Steve Lane and Jose Guell
LASEK, PRK, AND EXCIMER LASER STROMAL SURFACE ABLATION
edited by
Dimitri T.Azar
Massachusetts Eye and Ear Infirmary
Schepens Eye Research Institute
and Harvard Medical School
Boston, Massachusetts, U.S.A.
Massimo Camellin
SEKAL Rovigo Micro Surgery
Rovigo, Italy
Richard W.Yee
Hermann Eye Center
and University of Texas Health Science Center
Houston, Texas, U.S.A.
Associate Editors
Robert T.Ang, MD,Sandeep Jain, MD,TakujiKato, MD, PhD Jae-Bum Lee, MD, PhD,Ronald R.Krueger, MD
Series Editors
Dimitri T.Azar, MD,Douglas D.Koch, MD
MARCEL DEKKER
NEW YORK
This edition published in the Taylor & Francis e-Library, 2005.
“To purchase your own copy of this or any of Taylor & Francis or Routledge’s collection of thousands of eBooks please go to http://www.ebookstore.tandf.co.uk/.”
Although great care has been taken to provide accurate and current information, neither the author(s) nor the publisher, nor anyone else associated with this publication, shall be liable for any loss, damage, or liability directly or indirectly caused or alleged to be caused by this book. The material contained herein is not intended to provide specific advice or recommendations for any specific situation.
Trademark notice: Product or corporate names may be trademarks or registered trademarks and are used only for identification and explanation without intent to infringe.
Library of Congress Cataloging-in-Publication Data A catalog record for this book is available from the Library of Congress.
ISBN 0-203-02591-1 Master e-book ISBN
ISBN: 0-8247-5434-4 (Print Edition)
Headquarters Marcel Dekker, 270 Madison Avenue, New York, NY 10016, U.S.A. tel: 212– 696–9000; fax: 212–685–4540
Distribution and Customer Service Marcel Dekker, Cimarron Road, Monticello, New York 12701, U.S.A. tel: 800–228–1160; fax: 845–796–1772
World Wide Web http://www.dekker.com/
The publisher offers discounts on this book when ordered in bulk quantities. For more information, write to Special Sales/Professional Marketing at the headquarters address above.
Copyright © 2005 by Marcel Dekker.
All Rights Reserved. Neither this book nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval system, without permission in writing from the publisher.
Preface
Ignotum per ignotius
[(To explain) the unknown by the more unknown]
How important are the subtle technical details in improving the clinical outcomes of LASEK surgery? Is the reduction of wavefront error greater in LASEK and Epi-LASIK than in LASIK? Does alcohol kill the corneal epithelial cells or does it allow epithelial cell proliferation to occur divorced from the unwanted process of epithelial cell migration over a denuded stroma? These questions, and many others, have fueled the debate regarding LASEK and Epi-LASIK vs. PRK and LASIK.
LASEK and Epi-LASIK are not universally employed refractive surgical procedures. They have several advantages over LASIK in patients with relatively thin pachymetry and in patients with borderline corneal topographical changes. However, the advantages of these techniques over PRK are yet to be established. Despite numerous anecdotal reports, clinical observations, and variations of surgical techniques suggesting certain advantages of LASEK and Epi-LASIK over PRK, other studies suggest possible advantages for PRK, at least in the early postoperative period. Clearly, large prospective randomized multi-center studies, carried out by experienced LASEK surgeons, are lacking. New techniques of LASEK also hold great promise to overcome some of its current limitations.
Despite the apparent and sometimes unavoidable bias toward LASEK and surface ablation in many chapters of this book, the aim is not to present an argument favoring these techniques, but rather to present a panoramic view of various aspects of these techniques. We focus on the indications, contraindications, and surgical techniques of stromal surface ablation and discuss the postoperative care, wound healing, clinical outcomes, and complications. Also included are several basic chapters discussing wavefront analysis, optical aberration changes after LASEK, the effect of alcohol on corneal cell-cell and cell-matrix interactions, and the pathogenesis and treatment options for postoperative stromal haze.
Inclusion of this book in our “Refractive Surgery Series” was initiated with the help of several of the associate editors, who had been postgraduate fellows at the Corneal and Refractive Surgery Service of the Massachusetts Eye and Ear Infirmary. Progress of this project was hindered by the lack of definitive answers to our questions in the peerreviewed literature. Completion of the first draft of the book would not have been possible without the efforts of Drs. Suphi Taneri and Puwat Charukamnoetkanok. Additional manuscripts from Drs. Massimo Camellin, Richard Yee, Ronald Krueger, and several other experienced LASEK surgeons provided more comprehensive coverage of the topic.
We acknowledge the support of Dr. Geoff Greenwood and Rosemary Doherty of Taylor and Francis, Inc. and their commitment to this series dedicated to Refractive Surgery. We also thank Leona Greenhill for editorial assistance. Special thanks go to
Rhonda Harris, who has managed this project with utmost dedication, care, and attention to detail.
We also thank the contributors for presenting the results of their investigations. Their work will not only help answer many important questions about LASEK and surface ablation, but also underscore the fact that many answers remain unknown. Yes, the field still suffers from explanations of the unknown by even more unknowns, but the observations (and opinions) of the contributors mark a step forward in the path of discovery in this important field. They pave the way for future scientific investigations, which will undoubtedly increase our understanding of LASEK and surface ablation and improve the visual outcomes of future patients undergoing conventional and customized keratorefractive surgery.
Dimitri T.Azar
Douglas D.Koch
Contents
|
Preface |
vi |
|
Contributors |
xii |
1. |
Overview of LASEK and Stromal Surface Ablation |
1 |
2. |
Suphi Taneri, MD and Dimitri T.Azar, MD |
|
Laser Subepithelial Keratomileusis (LASEK): Theoretical Advantages |
15 |
|
|
Over LASIK |
|
3. |
Paolo Vinciguerra, MD and Daniel Epstein, MD, PhD |
|
Indications and Contraindications of LASEK |
22 |
|
|
Jae Bum Lee, MD, Puwat Charukamnoetkanok, MD and Dimitri T.Azar, |
|
4. |
MD |
|
LASEK Preoperative Considerations |
28 |
|
5. |
Robin F.Beran, MD, FACS |
|
LASEK Preoperative Evaluation |
36 |
|
6. |
Chun Chen Chen, MD and Dimitri T.Azar, MD |
|
LASEK Techniques |
53 |
|
7. |
Chun Chen Chen, MD, Joel Javier, MD, and Dimitri T.Azar, MD |
|
Camellin LASEK Technique |
85 |
|
8. |
Massimo Camellin, MD |
|
Butterfly LASEK |
95 |
|
9. |
Puwat Charukamnoetkanok, MD and Suphi Taneri, MD |
|
Epithelial Flap Hydrodissection and Viscodissection in Advanced Laser |
102 |
|
|
Surface Ablation (ALSA) |
|
10. |
Richard C.Rashid, MD |
|
Surface Ablation Without Alcohol: Gel-Assisted LASEK and Epi- |
127 |
|
|
LASIK using Epilift System |
|
11. |
Puwat Charukamnoetkanok, MD and Dimitri T.Azar, MD |
|
Epi-LASIK: Surface Ablation Without Alcohol |
133 |
|
|
Ioannis G.Pallikaris, MD, PhD, Vikentia J.Katsanevaki, MD, Maria I. |
|
12. |
Kalyvianaki, MD, Irini I.Naoumidi, PhD, and Richard W.Yee, MD |
|
Postoperative Management of LASEK |
142 |
|
13. |
Ahn Nguyen, MD, Amy Scally, OD, and Dimitri T.Azar, MD |
|
LASEK Enhancements |
152 |
|
|
Lee Shahinian, Jr, MD |
|
14. LASEK in High and Low Myopia |
156 |
Chris P.Lohmann, MD, PhD, David O’Brart, MD, Ann Patmore, BSC, John |
|
Marshall, PhD, Christoph Winkler von Mohrenfels, MD, Bernhard Gabler, |
|
MD, and Wolfgang Herrmann, MD |
|
15. |
LASEK vs. PRK: Comparison of Visual Outcomes |
170 |
16. |
Minh Hanh Duong, MD and Damien Gatinel, MD |
|
LASEK vs. LASIK: Comparison of Visual Outcomes |
176 |
|
|
Neal J.Peterson, MD, Alice Z.Chuang, PhD, Rajy M.Rouweyha, MD, and |
|
17. |
Richard W.Yee, MD |
|
Topography-Based Aberration in LASEK vs. PRK and LASIK |
192 |
|
|
Michael K.Smolek, PhD, Stephen D.Klyce, PhD, Loan Nguyen, MD, Richard |
|
18. |
W.Yee, MD, John P.Stokes, MD, Marguerite B.McDonald, MD |
|
LASEK Complications |
211 |
|
19. |
Jae Bum Lee, MD, PhD |
|
Management of LASEK Complications |
224 |
|
20. |
Massimo Camellin, MD |
|
Wavefront Analysis, Principles, and LASEK Application |
235 |
|
21. |
Ronald R.Krueger, MD, Patrick C.Yeh, MD, and Dimitri T.Azar, MD |
|
Customized Ablation and LASEK |
259 |
|
22. |
Erin D.Stahl, MD and Daniel S.Durrie, MD |
|
Comparison of Wavefront-Guided Photorefractive Keratectomy and |
270 |
|
|
LASEK Treatments for Myopia and Myopic Astigmatism |
|
23. |
Zoltán Z.Nagy, MD |
|
Wound Healing After PRK, LASIK, and LASEK |
276 |
|
24. |
Takuji Kato, MD |
|
Biochemical Basis of Epithelial Dehiscence and Reattachment After |
289 |
|
|
LASEK |
|
|
Eric E.Gabison, MD, Hailton B.Oliveira, MD, Jin-Hong Chang, PhD, and |
|
25. |
Dimitri T.Azar, MD |
|
Refractive Surgical Wound Healing Mechanisms Revisited: A Glimpse |
300 |
|
|
at the Future of LASEK |
|
26. |
James V.Jester, PhD |
|
Mitomycin C and Haze: Natural Progression |
313 |
|
|
Mujtaba A.Qazi, MD, Jay S.Pepose, MD, PhD, Irwin Y.Cua, MD, Saira A. |
|
27. |
Choudhri, MD, and M.Azim Mirza, MD |
|
Mitomycin C and Surface Ablation |
343 |
|
28. |
Scott D.Barnes, MD and Dimitri T.Azar, MD |
|
Use of Autologous Serum to Reduce Haze After LASEK |
354 |
|
|
Steven B.Yee, MD, Ning Lin, MD, OD, Alice Z.Chuang, PhD, and Richard |
|
29. |
W.Yee, MD |
|
LASEK After Corneal and Intraocular Procedures |
365 |
|
|
Puwat Charukamnoetkanok, MD and Dimitri T.Azar, MD |
|
30. LASEK After Penetrating Keratoplasty |
371 |
Steven B.Yee, MD, Ning Lin, MD, OD, Corey B.Westerfeld, MD, and |
|
Richard W.Yee, MD |
|
Index |
381 |
